The biogenesis and biology of amyloid β oligomers in the brain

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• The amyloid cascade hypothesis, central to Alzheimer's disease pathogenesis, posits that amyloid beta (Aβ) accumulation drives neurodegeneration.
• Numerous clinical trials targeting Aβ have failed, prompting re-evaluation of this hypothesis and therapeutic strategies.
• Understanding Aβ's complex biology is crucial for developing effective treatments.

Purpose of the Study:

• To critically analyze the biogenesis and biological functions of amyloid beta (Aβ).
• To discuss the multifaceted effects of Aβ on the human brain.
• To provide insights for refining future therapeutic approaches targeting Aβ.

Main Methods:

• Review of existing literature on amyloid beta (Aβ) biogenesis and function.
• Analysis of atomic structure and biological effects of Aβ.
• Perspective-based discussion of therapeutic implications.

Main Results:

• The amyloid cascade hypothesis faces significant challenges due to repeated clinical trial failures.
• Aβ exhibits complex biological roles beyond simple aggregation, influencing neuronal function and brain pathology.
• Current understanding of Aβ's atomic arrangement and downstream effects is incomplete.

Conclusions:

• Rethinking the direct targeting of Aβ in Alzheimer's disease is necessary.
• Future therapeutic strategies should consider Aβ's intricate biology and diverse brain effects.
• Further research into Aβ's fundamental mechanisms may reveal novel therapeutic targets.